(Q43067624)

13 November 2017

Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study (English)

1 reference

13 November 2017

1 reference

10

J Hebebrand

1 reference

13 November 2017

9

H Remschmidt

1 reference

13 November 2017

S Gebhardt

1

1 reference

13 November 2017

F M Theisen

2

1 reference

13 November 2017

M Haberhausen

3

1 reference

13 November 2017

M Heinzel-Gutenbrunner

4

1 reference

13 November 2017

P M Wehmeier

5

1 reference

13 November 2017

J-C Krieg

6

1 reference

13 November 2017

W Kühnau

7

1 reference

13 November 2017

J Schmidtke

8

1 reference

13 November 2017

1 April 2010

1 reference

Journal of Clinical Pharmacy and Therapeutics

13 November 2017

1 reference

13 November 2017

35

1 reference

13 November 2017

2

1 reference

13 November 2017

207-211

1 reference

Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents

13 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Pharmacogenetics of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Genetic variants of the serotonin system and weight change during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

-759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

CYP2D6 polymorphisms and atypical antipsychotic weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Susceptibility genes for the side effect of antipsychotics on body weight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01084.X

10.1111/J.1365-2710.2009.01084.X

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference